NextPharma develops and manufactures food supplements for brand owners and retailers across Europe. We offer formulation development, pilot batches, and industrial-scale production and packaging across specialist sites operating under GMP and ISO 22000 standards.
Explore our full services overview to see how Health & Nutrition fits into our broader offer.
01
02
Plant-based soft capsule solution for oils, complex pastes and semi-solid fills. Suitable for vegan, vegetarian and natural product ranges, as well as animal nutrition and cosmetic applications. Backed by over 30 years of capsule manufacturing expertise.
Primary site: Ploërmel, France.
03
GMP manufacturing of oral solutions and suspensions.
Monthly capacity: 45 million bottles and 100 million ampoules.
Batch sizes from 3,000 to 15,000 litres.
Primary site: Limay, France.
04
High-volume production of chewable and standard compressed tablets, including modified-release formats. Suited to calcium, vitamin D3 & K2 and combination products.
Annual Capacity: up to 2,800 million tablets.
Primary site: Asker, Norway.
05
Advanced filling capability for both gelatin and HPMC capsules. Suitable for formulations requiring improved bioavailability or fast dissolution. Coating options available.
Primary site: Edinburgh, UK.
Quality, Documentation and Traceability
Our quality systems, documentation and batch controls are aligned with pharmaceutical standards across all sites. This is what that means in practice:
The Ploërmel site holds Ecocert (organic), Halal, Kosher and Friend of the Sea certifications, available on request. GMP certification applies to Edinburgh and Asker. Site-specific regulatory status is confirmed during supplier qualification.
The Ploërmel site operates an in-house analytical laboratory with 20 HPLC units, covering vitamin assay, DHA quantification, and full in-process and release testing, keeping method ownership within the manufacturing team and reducing dependence on external laboratories.
We support Health & Nutrition customers across the full product lifecycle, from ingredient specification through to commercial batch release.
| Stage | Scope | Timeline |
| Development | Ingredient sourcing and specification, formulation and process development, analytical method development, stability studies | 1–3 months for standard formulations |
| Pilot and scale-up | Technical trials at pilot scale, process optimisation, QC review, regulatory affairs support | Confirmed at project briefing |
| Commercial manufacturing | Industrial-scale production with full batch documentation, quality release and traceability | Pilot batch size according to the dosage form |
| Packaging | Bottles, blisters, sachets and ampoules; secondary packaging and serialisation options; worldwide distribution support | Confirmed at project briefing |
Development and manufacturing are co-located at each site, shortening iteration cycles and reducing handover risk between teams.
For brand owners looking to launch without a full development cycle, we offer a catalogue of validated, production-ready softgel capsule formulations across a range of health categories, including:
Contact the Health & Nutrition team for the current formulation catalogue and available shelf-life data.
Development network and site capabilities
Development activities are supported by specialist centres of excellence across Europe, each aligned to specific technologies and dosage forms.
Our Health & Nutrition manufacturing network spans four specialist sites across Europe.
| Site | Primary capability |
| Ploërmel, France | Softgel capsules, vegetal capsules and lipid-based formulations |
| Asker, Norway | High-volume chewable tablets (calcium, vitamin D3) |
| Limay, France | Oral liquids and suppositories |
| Edinburgh, UK | Liquid-filled hard capsules and high-containment |
Explore our full manufacturing network
Please share your project brief with us, subject to a non disclosure agreement (formulation, dosage form, target market, volumes, specific ingredients or active ingredients, etc.)
Share your dosage form, target volumes, markets and development stage with our Health & Nutrition team. We will confirm technical fit, outline development and manufacturing options, and provide relevant quality and regulatory documentation for your programme.
For standard softgel capsule formulations using qualified raw materials, development typically takes 1–3 months. Complex formulations or novel ingredients will require longer. Ready-to-Go formulations can significantly reduce time to first batch.
| Product type | Packaging formats |
| Softgel capsules | Blisters (available soon) |
| Oral liquids | Blisters and bottles |
| Chewable tablets | Pillbox |
| Liquid-filled hard capsules | To be confirmed at project briefing |
We provide full batch documentation, analytical method dossiers, stability data and CMC-level documentation as required. We provide regulatory affairs support for multi-country registrations.
Yes. We support registrations in multiple international markets, including APAC and the China cross-border channel. Country-specific documentation is available on request.
Yes. All production, regardless of regulatory classification, is conducted under GMP. This applies to quality systems, documentation, change control and batch release.
Stability data is available for our validated softgel capsule formulations. Contact the Health & Nutrition team for current shelf-life documentation.
MOQ varies by dosage form and site. Contact the Health & Nutrition team with your target volumes and dosage form to receive a technical and commercial assessment.
Change control procedures are documented and applied consistently across all sites. Any changes to formulation, process or raw materials follow a structured review and approval process, with full traceability maintained through
Whether it's development, manufacturing or supply. Tell us about your project and our experts will get back to you.
